Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey Liveringhouse, Bradford A. Perez, Kujtim Latifi et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 18
Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative ManagementLeila T. Tchelebi, Michael D. Chuong, Sarah E. Hoffe et al.|Cancer Control|2020Cited by 12
Development of a Radiation Oncology Fee Schedule Model for Industry-Sponsored Clinical TrialsJanis V. de la Iglesia, Eduardo G. Moros, K. Yamoah et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 0